Global CRO footprint ARIANNE operates as a multinational CRO offering clinical and regulatory services across North America, Europe, Australia and emerging economies in Asia, South America and Africa, presenting opportunities to partner on regional trials, site expansion, and cross-border regulatory strategy.

End-to-end regulatory expertise With in-house regulatory personnel in all service regions and emphasis on FDA and ICH guidelines, ARIANNE can help clients navigate complex submissions and accelerate approvals, suggesting upsell on regulatory strategy, dossier preparation, and ongoing compliance support.

Clinical trial expansion Capabilities to conduct Phase I to IV trials in diverse markets with fast enrollment and high retention indicate potential to pitch expansion studies, patient recruitment services, and site management in high-growth regions.

Tech-enabled operations Utilizing consent management, CMS, analytics tools and CRM platforms (WordPress, HubSpot, Google Analytics, etc.) positions ARIANNE to offer digital patient engagement, eConsent optimization, data analytics, and reporting enhancements for sponsors.

Mid-market strength With a mid-size employee base and revenue in the lower mid-market range, ARIANNE is well-suited to target biotech and pharma sponsors seeking flexible, cost-effective CRO partnerships for mid-to-large-scale trials and ongoing regulatory support.